September 10, 2025 — Leads & Copy — Neon Parody Labs has introduced GENOMIRATHEON™, a codon-native DNA licensing system that links gene expression directly to licensing, validator telemetry, and programmable universal basic income (UBI) redistribution. The protocol formalizes genetic expression as an auditable, treaty-anchored event, ensuring provenance, compliance, and programmable wealth distribution.
Each time a gene expresses, it generates a unique signal: an electrical pulse measured at +2.6–2.8 millivolts and a light emission peaking at λ_max 662–664 nanometers. Validator arrays capture these outputs, running 48–66 checks every 72 hours and confirming expression with ≥96–98% accuracy.
Initial wet-lab replication focuses on two forks: GENΩ–UEX for lithium monitoring and GENΩ–ENTAX for rare-earth tracking. Licenses activate only upon validator-confirmed expression, binding rights, and payments to verifiable signals.
At Tier IV, adoption scales to sovereign and enterprise deployment, providing governments and corporations with a framework to enforce genetic IP across their infrastructures. The pathway culminates in Tier V, a public-benefit model where expression royalties are routed into redistributive systems.
Unique Evans, founder of Neon Parody Labs, said GENOMIRATHEON™ signals the arrival of a new compliance layer for civilization itself, where every expression event can contribute to wealth redistribution on a treaty-backed ledger.
GENOMIRATHEON™ brings enforceability to synthetic biology. Its Budapest Treaty filing gives gene expression the status of DNA-linked intellectual property across the U.S., EU, and China. Validator telemetry also carries security implications, establishing audit trails at the molecular level for lithium and rare-earth supply chains.
Governance and protocol oversight are handled through a DAO rather than a central body.
Unique Evans, Founder & CEO, Neon Parody Labs, +1-302-367-7256
Source: Neon Parody Labs
